Association of Serum 25-Hydroxyvitamin D Levels and Vitamin D Dietary

Intake with Metabolic Syndrome: A Case Control Study by Ghanei, Laleh et al.
JRHS 2015; 15(1): 32-36 
 
  
 
 
JRHS 
Journal of Research in Health Sciences 
 
journal homepage: www.umsha.ac.ir/jrhs 
 
Original article 
 
Association of Serum 25-Hydroxyvitamin D Levels and Vitamin D Dietary 
Intake with Metabolic Syndrome: A Case Control Study 
 
Laleh Ghanei (MD)
a
, Amir Ziaee (MD)
a*
, Parsa Rostami (MD)
a
, Sonia Oveisi (PhD)
a
, Neda Esmailzadehha (MD)
a
, 
Amir Mohammad Kazemifar (MD)
a
, Ali Zargar (MD)
a
 
 
a
 Metabolic Diseases Research Center, Qazvin University of Medical Sciences, Qazvin, Iran 
 
ARTICLE INFORMATION  ABSTRACT 
Article history: 
Received: 01 October 2014 
Revised: 08 November 2014 
Accepted: 03 December 2014 
Available online: 09 December 2014 
 Background: Association between the vitamin D deficiency and metabolic syndrome (MetS) has 
previously been noted and reported to be controversial. The aim of this study was to determine 
the association of serum 25 (OH) D Level and Vitamin D dietary intake with MetS among Iranian 
population. 
Methods: This analytical study was conducted on 122 patients with MetS based on the ATPIII 
criteria and 128 subjects without MetS as control from September 2010 to April 2011. Serum 
levels of calcium, phosphorus and 25(OH) D were compared between the two groups. A food 
frequency questionnaire (FFQ) was used to calculate dietary intake. Data were analyzed using 
Chi- square test, t-test, Mann-Whitney U test and logistic regression analysis. 
Results: Serum concentrations of 25 (OH) D, calcium and phosphorus and calcium intake were 
significantly lower in subjects with MetS compared to the subjects without MetS. 98.4% of 
subjects with MetS and 88.3% without MetS had Vit. D deficiency and this difference was 
statistically significant (P=0.005). In regression analysis, lower concentration of serum 25 (OH) 
D, calcium and phosphorus and lower calcium and diary intake were predictors of MetS. 
Conclusions: Serum 25 (OH) D Level, calcium and phosphorus and calcium intake are 
associated with metabolic syndrome. However, the mechanism of this association requires 
further studies. 
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Introduction 
itamin D (Vit. D) has various roles in human life 
including bone and muscle functions, and normal 
growth
1
. Its roles in bone mineralization, promoting 
intestinal absorption of calcium and phosphorus, prevention 
of cancer, both through genomic and non-genomic 
mechanisms, adjustment of immune system functions, and 
glucose homeostasis has been confirmed. Vit. D deficiency 
would result in various diseases such as rickets, osteoporosis, 
bone fracture, certain types of cancers, hypertension, 
cardiovascular diseases, multiple sclerosis, type 1 diabetes 
mellitus, autoimmune diseases, and dental diseases
2-4
.
 
1, 25 
(OH)2 Vit. D mediates function of more than 200 genes; 
include genes responsible for synthesis of renin, insulin, and 
cytokines
2
.  
 Despite its importance in body homeostasis, Vit. D 
deficiency is highly prevalent worldwide
5, 6
. It has been 
claimed that 30-50% of children and adults in different parts 
of the world suffer from Vit. D deficiency
6-8
. It has even been 
about twice more prevalent in Chinese elderly and Korean 
menopaused women
9, 10
. The same is true for Iranian
6, 11, 12
. 
Metabolic syndrome (MetS) is defined as; central obesity, 
insulin resistance, abnormal glucose tolerance test, 
hypertriglyceridemia, low level of high density lipoprotein 
cholesterol (HDL), and hypertension. It is associated with 
risks of diabetes, cardiovascular diseases, and their resultant 
morbidity and mortality. Its prevalence is increasing, 
currently known as an epidemic disease worldwide
13
. Various 
causative factors have been suggested for MetS; including 
Vit. D deficiency. There are some studies that have proposed 
negative relationship between serum concentration of 25 
(OH) D and occurrence of MetS or its components
14,15
. 
However, other studies have not supported this 
relationship
16,17
. Theoretically, the roles of Vit. D in normal 
function of beta- cells of pancreas and insulin secretion and 
regulation of lipolysis explain the relationship between the 
serum concentration of 25 (OH) D and occurrence of MetS, 
reported to be so5, 18 but this relationship, is not found in 
another study
19
.   
Both MetS and Vit. D deficiency are prevalent in Iran as 
other Asian countries. Metabolism of Vit. D and prevalence 
of MetS are partly affected by ethnicity and lifestyle.  The 
aim of this study was to determine the association of serum 
25 (OH) D Level and Vit. D dietary intake with metabolic 
syndrome among Iranian population.  
V 
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Methods 
This analytical study was conducted on 250 subjects (122 
with MetS and 128 as control group)  identified in the Qazvin 
Metabolic Diseases Study (QMDS), Iran.  
The research project was approved by the Medical 
Research Ethics Committee of Qazvin University of Medical 
Sciences. All subjects gave their written informed consent 
form.  
Details of sampling method and data collection of the 
QMDS have been published elsewhere
20
. All households of 
the Minoodar district had profiles at the health center and the 
sampling unit was the household. Subjects were invited by 
phone call to attend the health center and after being fully 
explained, their written informed consent for the participation 
was obtained. Overall, 1107 subjects aged >20 yr old were 
selected by multistage cluster random sampling methods 
from residents of this district of Qazvin because of their 
similar socioeconomic status. The subjects were studied in a 
cross sectional design from September 2010 to April 2011. A 
self-reported questionnaire was used for social and 
demographic information. Two practitioners recorded 
medical history, family history, medication, and physical 
examination for all subjects. Waist circumference (WC), 
weight, height and body mass index (BMI) were measured 
after 12-14 h overnight fasting. In a seated position, blood 
pressure (BP) was measured three times by a mercury 
sphygmomanometer and after a 15 min rest on a single 
occasion. Blood levels of glucose, insulin, triglycerides 
(TGs), total cholesterol, high-density lipoprotein cholesterol 
(HDL) and low-density lipoprotein cholesterol (LDL) were 
measured for all subjects after 12-14 h overnight fasting and 
in the same laboratory. Oral glucose tolerance test (OGTT) 
by 75 g glucose was performed on subjects without previous 
diagnosis of diabetes. 
MetS was defined according to the ATP III criteria if at 
least three of the following conditions were met: WC > 102 
cm in men and > 88 cm in women, fasting plasma glucose 
(FPG) ≥ 100 mg/dl (includes diabetes), TGs > 150 mg/dl, 
HDL < 40 mg/dl in men and < 50 mg/dl in women, systolic 
blood pressure > 130 mmHg or diastolic blood pressure > 85 
mmHg
21
. Given this information, presence or absence of 
MetS was known for all study subjects and 328 (30.6%) of 
them had MetS. 
Totally, 122 subjects with MetS were selected and 128 
subjects without MetS were matched for age, gender, marital 
status, education level and occupation as control group. 
Subjects with diseases related to Vit. D (such as rickets), 
cancer, hepatic and renal disease or on treatment with drugs 
that could affect the Vit. D metabolism (such as phenytoin) 
were excluded from this study. Serum concentrations of 25 
(OH) Vit. D, Calcium and Phosphorus were measured. 25 
(OH) Vit D levels were measured by ELISA using reagent 
(IDS Company, Germany). Mean intra- and interassay 
coefficients of variation were 5.3 and 4.6, respectively. 25 
(OH) D concentrations above 30 ng/ml were considered as 
Vit. D sufficiency. Vit. D insufficiency was defined as 20< 
25 (OH) D <30 ng/ml and25 (OH) D lower than 20 ng/mlwas 
considered as Vit. D deficiency
2
. A 168-item semi-
quantitative food frequency questionnaire (FFQ) was used to 
calculate dietary intake. Validity and reliability of this 
questionnaire were confirmed previously
22
. A list of foods 
has been developed in this questionnaire with a standard 
serving size. Food consumption frequency was self-reported 
by study subjects on a daily, weekly or monthly basis. The 
food intake was analyzed using "Nutrition 4, version 3.5.2" 
software (Nutrition 4, 2011).  
The normality of variables was examined by Kolmogorov 
Smirnov test. Categorical variables were described as number 
(percent). Quantitative variables were described as mean ± 
SD. Independent samples t-test and Mann-Whitney U test 
were used to compare quantitative parameters with normal 
and abnormal distribution between the two groups. Chi- 
square test was used to compare qualitative variables. 
Multiple logistic regression analysis was performed to 
investigate the independent association of MetS, Vit. D and 
other potential risk factors. SPSS software version 16.0 was 
used for statistical analysis. P-value less than 0.05 were 
considered significant.    
Results 
Overall, 122 subjects with MetS and 128 subjects without 
MetS were evaluated. Mean age was 46.3±11.8 yr in subjects 
with MetS and 45.3±12.3 in subjects without MetS and the 
difference was not statistically significant (P= 0.464). The 
groups had no statistically significant difference in their 
demographic characteristics (Table 1). BMI was 24.8± 3.7 
kg/m
2
 (18.1-37.2) in subjects without MetS, while it was 
28.3± 3.7 kg/m
2 
(18.4-37) in subjects with MetS and this 
difference was statistically significant (P< 0.001). 
Table 1: Demographic characteristics of the study subjects 
Variables 
Cases with MetS 
(n= 122) 
Controls without 
MetS (n= 128) 
 
Number Percent Number Percent P value 
Gender     0.267 
Male 62 50.8 74 57.8  
Female 60 49.2 54 42.2  
Marital status     0.486 
Single 8 6.6 12 9.5  
Married 109 89.3 112 88.9  
Divorced 1 0.8 0 0.0  
Widow 4 3.3 2 1.6  
Education level     0.358 
Illiterate 11 9.2 5 4.2  
Less than 
high school 
67 55.8 64 53.3  
High school 
diploma 
28 23.3 35 29.9  
College 
education 
14 11.7 16 13.3  
Occupation     0.571 
Employed 32 26.2 32 25.0  
Unemployed 4 3.2 4 3.1  
Retired 34 27.8 46 35.9  
Housewife 52 42.6 46 35.9  
According to the ATP III criteria, 28 (21.9%), 19 
(14.8%), 60 (46.9%), 18 (14.1%) and 35 (27.3%) of subjects 
without MetS had High WC, high BP, low HDL, high TGs 
and high FPG, respectively. Seventy-eight (63.9%), 62 
(50.8%), 111 (91%), 96 (78.7%) and 92 (75.4%) of subjects 
with MetS had high WC, high BP, low HDL, high TGs and 
high FPG, respectively. Thirty-seven subjects with MetS and 
four subjects without MetS were diabetic. Of them, 25 
subjects with MetS and 3 without MetS were on anti-diabetic 
treatment. 
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Clinical and laboratory characteristics of the subjects are 
shown in Table 2. The groups had statistically significant 
differences in all components of MetS. Serum concentrations 
of 25 (OH) D, calcium and phosphorus and calcium intake 
were significantly different between two groups (Table 2). 
Distribution of Vit. D in subjects with and without MetS has 
been showed in figure 1. 98.4% of subjects with MetS and 
88.3% of subjects without MetS had Vit. D deficiency while 
1.6% of subjects with MetS and 6.2% of subjects without 
MetS had Vit. D sufficiency and this difference was 
statistically significant (P=0.005). Eighty percent of subjects 
with MetS had vitamin D concentration less than 10 ng/ml, 
while the corresponding number was 41.7% in subjects 
without MetS.  
In multiple logistic regression analysis, lower concentration 
of serum 25 (OH) D, calcium and phosphorus and lower 
calcium and diary intake were predictors of MetS (Table 3). 
We evaluated the studied groups for their WC, presence of 
hypertension, HDL levels, TG levels, and FPG; while 
categorizing them according to their Vit. D concentrations. 
The differences were statistically significant for WC, HDL 
and TG levels (P= 0.001, P=0.001, and P=0.012, 
respectively); but not for hypertension, and FPG. 
 
Figure 1: Distribution of vitamin D in subjects with and without metabolic 
syndrome 
Table 2: Clinical and laboratory characteristics of the study subjects  
Variables 
Cases with MetS 
(n= 122) 
Controls without MetS 
(n= 128) 
P value Mean SD Mean SD 
Systolic blood pressure (mmHg) 121.0 18.0 112.3 15.0 0.001 
Diastolic blood pressure (mmHg) 76.8 12.2 70.2 10.4 0.001 
Waist circumference (cm), male 99.0 8.6 89.3 8.0 0.001 
Waist circumference (cm), female 96.2 9.6 88.1 11.6 0.001 
Fasting plasma glucose (mg/dL) 113.1 45.1 94.7 16.6 0.001 
Triglycerides (mg/dL) 213.2 92.2 116.5 46.2 0.001 
LDL (mg/dL) 116.1 26.3 105.9 21.4 0.001 
HDL (mg/dL), male 34.4 6.5 41.9 7.7 0.001 
HDL (mg/dL), female 40.4 5.6 47.0 9.9 0.001 
Serum calcium (mg/dL) 8.7 0.3 9.1 0.4 0.001 
Serum phosphorus (mg/dL) 3.3 0.2 3.9 0.3 0.001 
Serum 25(OH) D (ng/ml) 9.6 5.4 14.5 10.5 0.001 
Vitamin D intake (μg/day) 3.5 11.1 4.2 11.1 0.205 
Calcium intake (mg/day) 686.9 263.5 785.7 286.7 0.008 
Phosphorus intake (mg/day) 1336.0 485.5 1439.6 372.1 0.084 
Dairy intake (servings/day) 1.1 0.6 1.4 0.9 0.001 
 
Table 3: Multiple Logistic regression analysis of metabolic syndrome predictors 
Variables 
Cases 
 with MetS 
Controls 
 without MetS 
Unadjusted 
OR (95% CI) P value 
Adjusted 
 ORa (95% CI) P value 
Serum Calcium (mg/dl)     
8.5-10.6  93 122 1.00  1.00  
<8.5 or >10.6 29 6 0.16 (0.06, 0.40) 0.001 0.14 (0.03, 0.70) 0.016 
Serum Phosphorus (mg/dl)       
3.3-5.5  66 119 1.00  1.00  
<3.3 54 1 0.01 (0.00, 0.08) 0.001 0.00 (0.00, 0.01) 0.001 
Serum 25(OH) D (ng/ml)       
>30  2 8 1.00  1.00  
<30 120 120 0.25 (0.05, 1.20) 0.084 0.78 (0.67, 0.91) 0.002 
Vitamin D intake - - 0.99 (0.97, 1.02) 0.686 0.99 (0.95, 1.04) 0.874 
Calcium intake - - 0.99 (0.99, 1.00) 0.015 1.00 (0.99, 1.01) 0.171 
Phosphorus intake - - 0.99 (0.99, 1.00) 0.088 0.99 (0.99, 1.00) 0.212 
Diary intake - - 0.46 (0.29, 0.72) 0.001 0.27 (0.08, 0.88) 0.030 
aORs adjusted for serum Calcium, serum Phosphorus, serum 25(OH) D, vitamin D intake, Calcium intake, Phosphorus intake and diary intake. 
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Discussion 
The current study was designed to determine association 
between Vit. D deficiency and MetS.  Results showed that 
Vit. D concentration was notably lower in subjects with MetS 
compared to subjects without MetS.  High prevalence of Vit. 
D deficiency was considerable. 
Both Vit. D deficiency and MetS cause most important 
health problems. Vit. D deficiency may lead to various 
dysfunctions in body metabolism while MetS may also 
increase the risk of cardiovascular diseases. Recent advances 
in technology and welfare, changes in lifestyle and nutritional 
habits have exposed Asian countries including Iran with side 
effects of so- called western lifestyle, such as MetS and its 
associated increased risk of cardiovascular diseases.  
On the other hand, Vit. D deficiency has become 
prevalent despite improvements in the socioeconomic status. 
In Tehran, the capital city of Iran, in 2004; 9.5, 57.6, and 14.2 
percent of studied individuals suffered from severe, 
moderate, and mild Vit. D deficiency, respectively
12
. In 
Isfahan City, 26.9, 23.9, and 19.6% prevalence for severe, 
moderate, and mild Vit. D deficiency, respectively in 2011 
has been reported 
6
 while another study conducted in five 
large cities of Iran has reported that more than 40% of the 
studied individuals (in various gender and age groups) had 
Vit. D deficiency
11
. We found that 88.3% of subjects without 
MetS and 98.4% of subjects with MetS had Vit. D 
deficiency. It seems that Vit. D deficiency becomes a 
frightening issue among Iranians.  
There are controversial reports about the relation between 
Vit. D deficiency and MetS or its components. Many studies 
have suggested relationship between Vit. D and MetS. 
However, their findings are not satisfactory and comparable. 
They differ in their methodology, studied population, study 
design, model of report, and method of analysis of Vit. D. 
Some of them are not matched for some imperative variables 
and some are performed on certain age or population groups, 
hence their results cannot be extrapolated to general 
population
19
. 
Serum concentration of 25 (OH) D is widely accepted as 
a standard measure for the evaluation of Vit. D adequacy in 
human; however, there is no consensus on it
23, 24
. 
Nevertheless, we considered levels higher than 30 ng/ml as 
normal serum concentration of 25 (OH) D. It is shown that 
this concentration of Vit. D is associated with optimal health 
status, minimum level of parathyroid hormone, and the least 
probability of bone fracture 
8, 25
. 
Cheng et al. have studied relationship between the serum 
concentrations of Vit. D and obesity, as well as its 
cadiometabloic risks on 3890 non-diabetic persons
15
. 
Accordingly, serum concentration of Vit. D had reverse 
association with WC, serum insulin concentration, 
subcutaneous adipose tissue (SAT) and visceral adipose 
tissue (VAT). They found that serum concentration of Vit. D 
was indirectly proportional to the fat content of body; even in 
individuals with BMI less than 25 kg/m
2
. They also found 
that frequency of Vit. D deficiency (serum concentration of 
Vit. D less than 20 ng/ml) is 3-fold in persons with high SAT 
and VAT; compared to persons with low SAT and VAT. 
They believed that Vit. D deficiency is related to body fat 
content, particularly visceral fat. Lender et al. have reported 
that serum concentration of 25 (OH) D decreases 0.46±0.22 
with every 1% increase in body fat mass, alongside with 
decrease in PTH level 0.78±0.29 
26
. Their findings are in 
favor of the effect of body fat content on distribution of Vit. 
D. Chiu et al. have found independent association between 
serum concentration of 25 (OH) D and insulin sensitivity 
index; but no similar association is found between Vit. D and 
response to insulin
5
. They have reported that components of 
MetS are more frequently seen in patients with low serum 
Vit. D (< 20 ng/ml). They have concluded that Vit. D 
deficiency has negative effect on function of beta cells of 
pancreas. McGill et al. have found significant negative 
relationship between serum level of Vit. D3 and body weight, 
BMI, and WC; but not with body fat content
16
. They believed 
that every 1 kg/m
2 
rise in BMI decreased vitamin D by 0.75 
nmol/l, while every increase in WC decreased it by 0.29 
nmol/l. There are other studies that have also found 
significant relation between serum levels of 25 (OH) D and 
MetS, as well as LDL concentration
23, 27
. In Iran MetS is 
more prevalent in men with Vit. D deficiency when 
compared to men with normal level of Vit. D
28
. The authors 
believed that Vit. D deficiency was an independent predictive 
variable for the occurrence of MetS. Findings of the present 
study about negative relationship between the occurrence of 
MetS and serum concentration of Vit D are in accordance 
with above-mentioned studies. 
On the other hand, there are some contradictory studies. 
Kim et al. have not found any relation between serum 
concentrations of Vit. D and MetS among Korean
1
.  
Nevertheless, they have found negative relation between 
serum concentrations of Vit. D and HDL level. Khader et al. 
have performed similar study in west Asia 
19
 and they did not 
found any significant relation between serum concentrations 
of Vit. D and MetS or its components. These studies might 
imply that the relation between serum concentration of Vit. D 
and MetS may not be factual among Asian people, 
particularly in west Asia. However, current study confirmed 
that the association is present even in this geographic area. 
Vit. D intake from animal sources is very low among 
Iranians 
25 
and this study claimed that 90-95% of them had 
Vit. D intake less than 10 micrograms/day and our findings in 
this study confirm this too.  
The authors chose subjects without MetS from same area 
as subjects with MetS and assessed them at the same time to 
avoid confounding factors such as sun exposure, 
socioeconomic status and seasonal variation.  However, we 
had some limitations in the present study as we did not 
measure duration of the sunlight exposure in the subjects to 
estimate the severity of Vit. D deficiency among exposed and 
non-exposed individuals. Another limitation for interpretation 
of the results was the high prevalence of Vit. D deficiency in 
this population. It might also help to clarify causes of Vit. D 
deficiency among studied population.  
Conclusions 
Vit. D deficiency is associated with MetS, however their 
cause and effect relation needs other studies. Design of 
clinical trials to treat patients with concurrent Vit. D 
deficiency and MetS with Vit. D supplementation and 
assessment of their response can be helpful. 
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